BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 21692067)

  • 1. Hospital racial composition and the treatment of localized prostate cancer.
    Pollack CE; Bekelman JE; Liao KJ; Armstrong K
    Cancer; 2011 Dec; 117(24):5569-78. PubMed ID: 21692067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Racial disparities in changing to a high-volume urologist among men with localized prostate cancer.
    Pollack CE; Bekelman JE; Epstein AJ; Liao K; Wong YN; Armstrong K
    Med Care; 2011 Nov; 49(11):999-1006. PubMed ID: 22005606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Racial Disparities in the Presentation, Early Definitive Surgical Treatment, and Mortality Among Men Diagnosed with Poorly Differentiated/Undifferentiated Non-metastatic Prostate Cancer in the USA.
    Lediju O; Ikuemonisan J; Salami SS; Adejoro O
    J Racial Ethn Health Disparities; 2019 Apr; 6(2):401-408. PubMed ID: 30506310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Racial/ethnic differences in receipt of pelvic lymph node dissection among men with localized/regional prostate cancer.
    Hayn MH; Orom H; Shavers VL; Sanda MG; Glasgow M; Mohler JL; Underwood W
    Cancer; 2011 Oct; 117(20):4651-8. PubMed ID: 21456009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Income inequality and treatment of African American men with high-risk prostate cancer.
    Ziehr DR; Mahal BA; Aizer AA; Hyatt AS; Beard CJ; D Amico AV; Choueiri TK; Elfiky A; Lathan CS; Martin NE; Sweeney CJ; Trinh QD; Nguyen PL
    Urol Oncol; 2015 Jan; 33(1):18.e7-18.e13. PubMed ID: 25306287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A multidimensional view of racial differences in access to prostate cancer care.
    Pollack CE; Armstrong KA; Mitra N; Chen X; Ward KR; Radhakrishnan A; Wong MS; Bekelman JE; Branas CC; Rhodes KV; Grande DT
    Cancer; 2017 Nov; 123(22):4449-4457. PubMed ID: 28727136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Getting back to equal: The influence of insurance status on racial disparities in the treatment of African American men with high-risk prostate cancer.
    Mahal BA; Ziehr DR; Aizer AA; Hyatt AS; Sammon JD; Schmid M; Choueiri TK; Hu JC; Sweeney CJ; Beard CJ; D'Amico AV; Martin NE; Lathan C; Kim SP; Trinh QD; Nguyen PL
    Urol Oncol; 2014 Nov; 32(8):1285-91. PubMed ID: 24846344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Racial differences in mortality among Medicare recipients after treatment for localized prostate cancer.
    Godley PA; Schenck AP; Amamoo MA; Schoenbach VJ; Peacock S; Manning M; Symons M; Talcott JA
    J Natl Cancer Inst; 2003 Nov; 95(22):1702-10. PubMed ID: 14625261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Racial Differences in the Surgical Care of Medicare Beneficiaries With Localized Prostate Cancer.
    Schmid M; Meyer CP; Reznor G; Choueiri TK; Hanske J; Sammon JD; Abdollah F; Chun FK; Kibel AS; Tucker-Seeley RD; Kantoff PW; Lipsitz SR; Menon M; Nguyen PL; Trinh QD
    JAMA Oncol; 2016 Jan; 2(1):85-93. PubMed ID: 26502115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Do hospitals provide lower quality of care to black patients for pneumonia?
    Mayr FB; Yende S; D'Angelo G; Barnato AE; Kellum JA; Weissfeld L; Yealy DM; Reade MC; Milbrandt EB; Angus DC
    Crit Care Med; 2010 Mar; 38(3):759-65. PubMed ID: 20009756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Racial treatment trends in localized/regional prostate carcinoma: 1992-1999.
    Underwood W; Jackson J; Wei JT; Dunn R; Baker E; Demonner S; Wood DP
    Cancer; 2005 Feb; 103(3):538-45. PubMed ID: 15612083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Racial disparity in primary and adjuvant treatment for nonmetastatic prostate cancer: SEER-Medicare trends 1991 to 1999.
    Zeliadt SB; Potosky AL; Etzioni R; Ramsey SD; Penson DF
    Urology; 2004 Dec; 64(6):1171-6. PubMed ID: 15596192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Race/ethnicity and the receipt of watchful waiting for the initial management of prostate cancer.
    Shavers VL; Brown ML; Potosky AL; Klabunde CN; Davis WW; Moul JW; Fahey A
    J Gen Intern Med; 2004 Feb; 19(2):146-55. PubMed ID: 15009794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Racial/ethnic disparities in the treatment of localized/regional prostate cancer.
    Underwood W; De Monner S; Ubel P; Fagerlin A; Sanda MG; Wei JT
    J Urol; 2004 Apr; 171(4):1504-7. PubMed ID: 15017208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Racial differences in definitive breast cancer therapy in older women: are they explained by the hospitals where patients undergo surgery?
    Keating NL; Kouri E; He Y; Weeks JC; Winer EP
    Med Care; 2009 Jul; 47(7):765-73. PubMed ID: 19536008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Racial inequities in the quality of surgical care among Medicare beneficiaries with localized prostate cancer.
    Nyame YA; Holt SK; Etzioni RD; Gore JL
    Cancer; 2023 May; 129(9):1402-1410. PubMed ID: 36776124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new approach to understanding racial disparities in prostate cancer treatment.
    Presley CJ; Raldow AC; Cramer LD; Soulos PR; Long JB; Yu JB; Makarov DV; Gross CP
    J Geriatr Oncol; 2013 Jan; 4(1):1-8. PubMed ID: 23828723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Racial differences in initial treatment for clinically localized prostate cancer. Results from the prostate cancer outcomes study.
    Hoffman RM; Harlan LC; Klabunde CN; Gilliland FD; Stephenson RA; Hunt WC; Potosky AL
    J Gen Intern Med; 2003 Oct; 18(10):845-53. PubMed ID: 14521648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Racial, Socioeconomic, and Geographic Disparities in the Receipt, Timing to Initiation, and Duration of Adjuvant Androgen Deprivation Therapy in Men with Prostate Cancer.
    Nguyen C; Lairson DR; Swartz MD; Du XL
    J Racial Ethn Health Disparities; 2019 Feb; 6(1):133-142. PubMed ID: 29959759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trends and black/white differences in treatment for nonmetastatic prostate cancer.
    Klabunde CN; Potosky AL; Harlan LC; Kramer BS
    Med Care; 1998 Sep; 36(9):1337-48. PubMed ID: 9749657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.